Grant

Leveraging NAMs to understand disease triggers, discover early biomarkers and develop new classes of therapeutic strategies for Type 1 Diabetes (U01 Clinical Trial Not Allowed)

CountryUnited States
DeadlineNot published
Published2026-11-05
SectorsHealth & life sciences
SourceGrants.gov (US)

Summary

Funding opportunity RFA-DK-28-113. CFDA: 93.KRP, 93.855

The buyer, the value, the full description and the link to the official notice are available with a free account.